151 related articles for article (PubMed ID: 5195904)
1. The role of the metabolism of p-aminosalicylic acid (PAS) in the treatment of tuberculosis. Interaction with the metabolism of isonicotinic acid hydrazide (INH) and the synthesis of cholesterol.
Lehmann J
Scand J Respir Dis; 1969; 50(3):169-85. PubMed ID: 5195904
[No Abstract] [Full Text] [Related]
2. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
Hanngren A; Borgå O; Sjöqvist F
Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864
[No Abstract] [Full Text] [Related]
3. [Administration by slow phleboclysis of isoniazid and para-aminosalicylic acid in the treatment of tuberculosis. Therapeutic effects and blood levels of the drug].
Mariani B; Bisetti A; Monzali G
G Ital Mal Torace; 1967; 21(2):81-92. PubMed ID: 5602966
[No Abstract] [Full Text] [Related]
4. The influence of para-aminosalicylic acid on isonicotinic acid hydrazide blood levels after oral and intravenous administration.
Kreukniet J; Blom van Assendelft PM; Mouton RP; Tasman A; Bangma PJ
Scand J Respir Dis; 1966; 47(4):236-43. PubMed ID: 5182291
[No Abstract] [Full Text] [Related]
5. [Excretion and concentration of tubazid, PAS and their metabolites in patients with tuberculosis and different functional conditions of kidneys].
Savula MM
Sov Med; 1973 Sep; 36(9):146-7. PubMed ID: 4756491
[No Abstract] [Full Text] [Related]
6. [Isoniazid and PAS metabolism and bacteriostatic activity of blood in adolescents with intrathoracic tuberculosis].
Tytor IaM
Probl Tuberk; 1975; (7):51-4. PubMed ID: 1082592
[No Abstract] [Full Text] [Related]
7. [Concentration and tolerance of INH and PAS in single daily doses. (Preliminary report)].
Vil'derman AM; Finn ER; Busygina RN; Draganiuk KA; Ezerskiĭ VF; Evgrafova ZA
Probl Tuberk; 1965; 43(11):30-4. PubMed ID: 5875728
[No Abstract] [Full Text] [Related]
8. [Concentration and excretion of isoniazid and PAS in patients with tuberculosis depending on the functional status of the kidney].
Savula MM; Kiselova ES
Vrach Delo; 1978 May; (5):119-22. PubMed ID: 676253
[No Abstract] [Full Text] [Related]
9. [Pharmacogenetic and interaction-model with some usual antitubercular agents].
Hanngren A; Boman G; Borgå O; Malmborg AS; Sjöqvist F
Nord Med; 1970 Sep; 84(38):1204. PubMed ID: 5469274
[No Abstract] [Full Text] [Related]
10. [Metabolism of PASA during administration of the preparation once and thrice daily].
Savula MM
Probl Tuberk; 1967; 45(4):70-4. PubMed ID: 5606807
[No Abstract] [Full Text] [Related]
11. [Peculiarities of PAS and tubazid metabolism in tuberculous patients treated with nerobol and ATP].
Sabula MM
Probl Tuberk; 1972; 50(1):47-50. PubMed ID: 5010779
[No Abstract] [Full Text] [Related]
12. [Liver function and INH and PAS metabolism in tuberculous adolescents with side reactions to chemotherapy].
Tytor IaN; Koropetskiĭ VI
Vrach Delo; 1977 Jun; (6):61-4. PubMed ID: 883281
[No Abstract] [Full Text] [Related]
13. [On metabolism of isonicotinic acid hydrazide (INH) and alpha-keto acids in tuberculous diabetics].
PFAFFENBERG R; IWAINSKY H; JAEHLER H; SIEGEL D
Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1960; 123():63-71. PubMed ID: 13735122
[No Abstract] [Full Text] [Related]
14. [Isonicotinic acid hydrazide, PAS and T-40 metabolism in the animal organism].
JAKIMOWSKA K
Postepy Biochem; 1958; 4(4):471-9. PubMed ID: 13623519
[No Abstract] [Full Text] [Related]
15. [Functional state of the liver and the metabolism of isoniazid and PASA in adolescents with intrathoracic tuberculosis].
Tytor IaN
Probl Tuberk; 1976 Jul; (7):29-32. PubMed ID: 959195
[No Abstract] [Full Text] [Related]
16. [Evaluation of initial combined chemotherapy with SM, INH and EB for pulmonary tuberculosis. 2. Comparison of SM, EB and INH regimen with that of SM, PAS and INH for experimental tuberculosis of mice].
Makiyama H
Kekkaku; 1971 Aug; 46(8):303-8. PubMed ID: 5570128
[No Abstract] [Full Text] [Related]
17. [Active fraction of isonicotinic acid hydrazide in the blood of tuberculosis patients during its combined use with PAS].
Dudchik GKh; Bilyk MA
Vrach Delo; 1981 Feb; (2):77-8. PubMed ID: 7222619
[No Abstract] [Full Text] [Related]
18. [Acetylation of p-aminosalicylic acid and isoniazid in the perfused liver as a competitive enzymatic process].
Wagner J; Dolezal V
Acta Univ Carol Med (Praha); 1965; ():Suppl 21:165+. PubMed ID: 5880954
[No Abstract] [Full Text] [Related]
19. [Pharmacokinetics of isoniazid, PAS, and cycloserin in acute and chronic alcoholic intoxication (experimental study)].
Ortenberg ZA
Probl Tuberk; 1978 Sep; (9):60-4. PubMed ID: 568263
[No Abstract] [Full Text] [Related]
20. [Laboratory control over the regularity of patients' taking PAS in the hospital].
Utkin VV; Voinova GI; Mel'nik EG; Egorkina ND; Dan'shina MIa
Lab Delo; 1972; 11():699-701. PubMed ID: 4124384
[No Abstract] [Full Text] [Related]
[Next] [New Search]
